Literature DB >> 11061280

A randomized controlled trial of prednisone in Alzheimer's disease.

H J Koch, A Szecsey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 11061280     DOI： 10.1212/wnl.55.7.1067

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  5 in total

Review 1.  Recent Advances in the Inhibition of p38 MAPK as a Potential Strategy for the Treatment of Alzheimer's Disease.

Authors:  Jong Kil Lee; Nam-Jung Kim
Journal:  Molecules       Date:  2017-08-02       Impact factor: 4.411

2.  Astrogliosis is a possible player in preventing delayed neuronal death.

Authors:  Hey-Kyeong Jeong; Kyung-Min Ji; Kyoung-Jin Min; Insup Choi; Dong-Joo Choi; Ilo Jou; Eun-Hye Joe
Journal:  Mol Cells       Date:  2014-04-22       Impact factor: 5.034

Review 3.  Alzheimer's Disease: Exploring the Role of Inflammation and Implications for Treatment.

Authors:  Mark E McCaulley; Kira A Grush
Journal:  Int J Alzheimers Dis       Date:  2015-11-17

Review 4.  Differentiation of Glial Cells From hiPSCs: Potential Applications in Neurological Diseases and Cell Replacement Therapy.

Authors:  Wei Zheng; Qian Li; Chao Zhao; Yuwei Da; Hong-Liang Zhang; Zhiguo Chen
Journal:  Front Cell Neurosci       Date:  2018-08-08       Impact factor: 5.505

5.  Electroacupuncture attenuates cognition impairment via anti-neuroinflammation in an Alzheimer's disease animal model.

Authors:  Mudan Cai; Jun-Hwan Lee; Eun Jin Yang
Journal:  J Neuroinflammation       Date:  2019-12-13       Impact factor: 8.322
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.